Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Veterans Affairs
Grant: 1K2 BX002712
U.S. Department of Veterans Affairs
Grant: 1K2 RX002947
National Institutes of Health, National Center for Complementary and Alternative Medicine
Grant: AT002688
Center for Neuroscience and Regenerative Medicine
Grant: 309698-7.01-65310
NIH EXITO Institutional Core
Grant: UL1GM118964
National Institutes of Health
Grant: TL1TR002371
NCCIH NIH HHS
Grant: T32 AT002688
BLRD VA
Grant: IK2 BX002712
RRD VA
Grant: IK2 RX002947
Oregon Institute for Occupational Health Sciences Pilot Project Award
FWCI
1.68
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial